Follow me on Twitter
I agree that content from Twitter will be displayed to me.
Head of Group
Director of Corporate Program
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Publications
Showing entries 1 - 5 out of 312
Li, E, Boujeddaine, N, Houtman, MJC, Maas, Sluijter, , Ecker, G, Weinzinger, A, van Ham, W & van der Heyden, M 2024, 'Development of new Kir2.1 channel openers from propafenone analogues', British Journal of Pharmacology. <https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.17377>
Digles, D, Ingles-Prieto, A, Dvorak, V, Mocking, TAM, Goldmann, U, Garofoli, A, Homan, EJ, Di Silvio, A, Azzollini, L, Sassone, F, Fogazza, M, Bärenz, F, Pommereau, A, Zuschlag, Y, Ooms, JF, Tranberg-Jensen, J, Hansen, JS, Stanka, J, Sijben, HJ, Batoulis, H, Bender, E, Martini, R, IJzerman, AP, Sauer, DB, Heitman, LH, Manolova, V, Reinhardt, J, Ehrmann, A, Leippe, P, Ecker, GF, Huber, KVM, Licher, T, Scarabottolo, L, Wiedmer, T & Superti-Furga, G 2024, 'Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily', Frontiers in Pharmacology, vol. 15, 1401599. https://doi.org/10.3389/fphar.2024.1401599
Granulo, N, Sosnin, S, Digles, D & Ecker, GF 2024, 'The macrocycle inhibitor landscape of SLC‐transporter', Molecular Informatics, vol. 43, no. 5, e202300287. https://doi.org/10.1002/minf.202300287
Huang, J, Osthushenrich, T, MacNamara, A, Mälarstig, A, Brocchetti, S, Bradberry, S, Scarabottolo, L, Ferrada, E, Sosnin, S, Digles, D, Superti-Furga, G & Ecker, GF 2024, 'ProteoMutaMetrics: machine learning approaches for solute carrier family 6 mutation pathogenicity prediction', Rsc advances, vol. 14, no. 19, 00748, pp. 13083-13094. https://doi.org/10.1039/d4ra00748d
Ferrada, E, Wiedmer, T, Wang, WA, Frommelt, F, Steurer, B, Klimek, C, Lindinger, S, Osthushenrich, T, Garofoli, A, Brocchetti, S, Bradberry, S, Huang, J, MacNamara, A, Scarabottolo, L, Ecker, GF, Malarstig, A & Superti-Furga, G 2024, 'Experimental and Computational Analysis of Newly Identified Pathogenic Mutations in the Creatine Transporter SLC6A8', Journal of Molecular Biology, vol. 436, no. 2, 168383. https://doi.org/10.1016/j.jmb.2023.168383
Activities
Showing entries 56 - 60 out of 202
Virtual Screening for New GABA Transporter 1 Inhibitors Based on Insights Acquired by Comparative Modeling
Andreas Jurik
,
Barbara Zdrazil
,
Harald H. Sitte
,
Gerhard Ecker
245th National Spring Meeting of the American-Chemical-Society (ACS)
Conference,
Poster presentation
..2013 - ..2013
The medicinal chemistry of drug transport – knowledge based ligand design.
Gerhard Ecker
3rd Portuguese Meeting on Medicinal Chemistry
Conference,
Talk or oral contribution
28.11.2012 - 28.11.2012
Ligand efficiency and lipophilic efficiency – versatile parameters for the design of inhibitors of transmembrane transporters?
Gerhard Ecker
5th Annual SFB35 Symposium "Transmembrane Transporters in Health and Disease"
Conference,
Talk or oral contribution
24.9.2012 - 24.9.2012
The molecular basis of drug-transporter interaction - science or fiction?
Gerhard Ecker
42nd Annual Drug Metabolism Gordon Research Conference
Conference,
Talk or oral contribution
12.7.2012 - 12.7.2012
Arzneistofftransporter und ihre Rolle in der Pharmaforschung
Gerhard Ecker
Talk or oral contribution
21.6.2012 - 21.6.2012